NovMetaPharma Co., Ltd. announced that it will issue 547,302 common shares par value KRW 500 per share at a price of KRW 12,790 per share for gross proceeds of KRW 6,999,992,580 on June 21, 2023. The transaction will include participation from new investors BNC Korea Co., Ltd. for 390,930 shares, KX Asset Co., Ltd. for 78,186 shares, and individual investor Woong Choi for 78,186 shares. The company will issue the common shares through third party allotment.

The securities issued in the transaction have a hold period of 1 year. The company is expected to close the transaction on June 29, 2023.